{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:59:30Z","timestamp":1780574370551,"version":"3.54.1"},"reference-count":46,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2017.00034","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T03:38:59Z","timestamp":1486438739000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose"],"prefix":"10.3389","volume":"7","author":[{"given":"Ming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.it.2014.04.006","article-title":"Tuberculosis vaccines\u2013rethinking the current paradigm","volume":"35","author":"Andersen","year":"2014","journal-title":"Trends Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol. Microbiol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.63.4.1491-1497.1995","article-title":"Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis","volume":"63","author":"Boesen","year":"1995","journal-title":"Infect. Immun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"146r","DOI":"10.1126\/scitranslmed.3004241","article-title":"A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge","volume":"4","author":"Bossart","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1128\/JVI.01572-09","article-title":"Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens","volume":"84","author":"Braxton","year":"2010","journal-title":"J. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1128\/JVI.01911-06","article-title":"Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations","volume":"81","author":"Clarke","year":"2007","journal-title":"J. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1128\/JVI.00200-10","article-title":"A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose","volume":"84","author":"Cobleigh","year":"2010","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/313891","article-title":"Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control","volume":"31","author":"Cohn","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J. Gen. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1128\/IAI.71.9.5407-5411.2003","article-title":"Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii","volume":"71","author":"Fachado","year":"2003","journal-title":"Infect. Immun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4049\/jimmunol.174.1.261","article-title":"IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart","volume":"174","author":"Fairweather","year":"2005","journal-title":"J. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1073\/pnas.83.21.8122","article-title":"Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase","volume":"83","author":"Fuerst","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tube.2004.10.002","article-title":"TB vaccines for the World","volume":"85","author":"Glyn Hewinson","year":"2005","journal-title":"Tuberculosis (Edinb)."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1128\/JVI.76.6.2730-2738.2002","article-title":"High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses","volume":"76","author":"Haglund","year":"2002","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.18.1.275","article-title":"CD8+ T cell effector mechanisms in resistance to infection","volume":"18","author":"Harty","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tube.2014.05.001","article-title":"Memory T cell subsets in tuberculosis: what should we be targeting?","volume":"94","author":"Henao-Tamayo","year":"2014","journal-title":"Tuberculosis (Edinb)."},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.vaccine.2005.07.115","article-title":"Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guerin can be augmented in an antigen independent manner by use of non-coding plasmid DNA","volume":"24","author":"Hogarth","year":"2006","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/JVI.71.7.5060-5068.1997","article-title":"Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins","volume":"71","author":"Johnson","year":"1997","journal-title":"J. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0952-7915(99)80067-3","article-title":"T cell responses to bacterial infection","volume":"11","author":"Kerksiek","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4161\/hv.27121","article-title":"A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection","volume":"10","author":"Kong","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","article-title":"Vesicular stomatitis virus: re-inventing the bullet","volume":"10","author":"Lichty","year":"2004","journal-title":"Trends Mol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.yjmcc.2014.07.021","article-title":"NK-derived IFN-gamma\/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis","volume":"76","author":"Liu","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1073\/pnas.1015153108","article-title":"Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection","volume":"108","author":"Millington","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1128\/IAI.74.2.1043-1049.2006","article-title":"The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance","volume":"74","author":"Pilione","year":"2006","journal-title":"Infect. Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"Publicover","year":"2005","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e37535","DOI":"10.1371\/journal.pone.0037535","article-title":"A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guerin immunisation in children and adults","volume":"7","author":"Ritz","year":"2012","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/mt.2008.59","article-title":"Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine","volume":"16","author":"Roediger","year":"2008","journal-title":"Mol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/IAI.68.1.214-220.2000","article-title":"Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens","volume":"68","author":"Skj\u00f8t","year":"2000","journal-title":"Infect. Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI19095","article-title":"Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease","volume":"112","author":"Sondel","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijmm.2015.07.006","article-title":"Signaling lymphocyte-activation molecule SLAMF1 augments mycobacteria BCG-induced inflammatory response and facilitates bacterial clearance","volume":"305","author":"Song","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.virol.2004.10.018","article-title":"Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach","volume":"331","author":"Tan","year":"2005","journal-title":"Virology"},{"key":"B45","volume-title":"WHO Vaccine-Preventable Dieases:Monitoring System 2004 Global Summary","author":"WHO","year":"2004"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1016\/j.vaccine.2014.05.052","article-title":"A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis","volume":"32","author":"Wu","year":"2014","journal-title":"Vaccine"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00034\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T23:32:58Z","timestamp":1601595178000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00034\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3389\/fcimb.2017.00034","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]}}}